Brief: Evotec And Centogene Expand Collaboration Into Gaucher Disease

Crown LiquidationCo NV in liquidatie

20/08/2020 06:32

Aug 20 (Reuters) - Evotec Se  EVTG.DE :
    * DGAP-NEWS: EVOTEC AND CENTOGENE EXPAND COLLABORATION INTO
GAUCHER DISEASE
    * CENTOGENE AND EVOTEC INTEND TO IDENTIFY NOVEL
DISEASE-MODIFYING
TARGETS
    * FIRST TARGET SELECTED FOR DEVELOPMENT OF A THERAPEUTIC
CANDIDATE
    * CENTOGENE CONTRIBUTES ACCESS TO ITS GLOBAL PROPRIETARY
RARE
DISEASE PLATFORM, EVOTEC WILL LEVERAGE ITS PROPRIETARY IPSC
PLATFORM AND DRUG DISCOVERY AND DEVELOPMENT EXPERTISE

Source text for Eikon:  urn:newsml:reuters.com:*:nEQ8fjyFXa
Further company coverage:  EVTG.DE 

 (Berlin Speed Desk)
 ((berlin.newsroom(at)thomsonreuters.com; +49 30 2201 33599;))